Subscribe to RSS
DOI: 10.1055/a-0634-7458
Sterile Keratitis
Sterile KeratitisPublication History
Publication Date:
16 August 2019 (online)
![](https://www.thieme-connect.de/media/augenheilkunde-u2d/201903/lookinside/thumbnails/10-1055-a-0634-7458_au_messmer-1.jpg)
Zusammenfassung
Sterile Keratitiden können als rein okuläres Problem, aber auch im Rahmen einer potenziell letalen Grunderkrankung auftreten. Diagnosestellung und Management dieser Erkrankung sind eine große Herausforderung für den Augenarzt. Neben therapeutischen Grundprinzipien für alle nicht infektiösen Keratitiden und Ulzerationen bestimmt die jeweilige Pathogenese die spezifische, u. U. lebensrettende Behandlung. Daher muss vor jeder Therapie eine akkurate, wegweisende Diagnose stehen.
Abstract
Sterile keratitis shows multiple manifestations. It may occur as an ophthalmological problem but can also be part of a systemic disease, including potentially lethal systemic vasculitis. Diagnosis as well as management of this disease is a challenging task for the ophthalmologist. There are therapeutic principles which apply to all non-infectious cases of keratitis and corneal ulcerations. Specific treatments, however, are determined by the pathogenesis and may differ. Therefore, an accurate diagnosis must guide therapeutic decision making. The correct diagnosis and management of sterile ulcerative keratitis is able to restore the patientʼs vision in most cases. In potentially lethal systemic disease it may even be able to save the patientʼs life.
-
Sterile Keratitiden haben eine Vielzahl sehr unterschiedlicher Ursachen. Sie können als rein okuläres Problem, aber auch als Symptom einer Grunderkrankung, z. B. einer potenziell letalen systemischen Vaskulitis auftreten.
-
Nicht nur die Diagnosestellung, auch das Management dieser Erkrankung ist eine große Herausforderung für den Augenarzt.
-
Es gibt zwar therapeutische Grundprinzipien, die für alle nicht infektiösen Keratitiden und Ulzerationen gelten, die spezifische Behandlung wird jedoch durch die jeweilige Pathogenese bestimmt und kann sehr verschieden sein. Daher muss vor jeder therapeutischen Intervention eine akkurate, wegweisende Diagnose stehen.
-
Die korrekte Diagnose und Therapie einer sterilen ulzerativen Keratitis kann zumeist den Visus wiederherstellen und das Auge erhalten, bei potenziell letalen Grunderkrankungen sogar das Leben des Patienten retten.
-
Weiterführende Literatur
- 1 Aaltonen V, Alavesa M, Pirilä L. et al. Case report: bilateral Moorenʼs ulcer in association with hepatitis C. BMC Ophthalmology 2017; 17: 239
- 2 Aifa A, Gueudry J, Portmann A. et al. Topical treatment with a new matrix therapy agent (RGTA) for the treatment of corneal neurotrophic ulcers. Invest Ophthalmol Vis Sci 2012; 53: 8181-8185
- 3 Bains RD, Elbaz U, Zuker RM. et al. Corneal neurotization form the supratrochlear nerve with sural nerve grafts: a minimally invasive approach. Plast Reconstr Surg 2015; 135: 397e-400e
- 4 Bonini S, Lambiase A, Rama P. et al. Phase II randomized, double-masked, vehicle-controlled trial of recombinant human nerve growth factor for neurotrophic keratitis. Ophthalmology 2018; 125: 1332-1343
- 5 Cao Y, Zhang W, Wu J. et al. Peripheral ulcerative keratitis associated with autoimmune disease. Pathogenesis and treatment. J Ophthalmol 2017; DOI: 10.1155/2017/7298026.
- 6 Das S, Mohamed A, Sangwan VS. Clinical course and outcomes in patients with Mooren ulcer who had cataract surgery. J Cataract Refract Surg 2017; 43: 1044-1049
- 7 Ding Y, Murri MS, Birdsong OC. et al. Terrien marginal degeneration. Surv Ophthalmol 2019; 64: 162-174
- 8 Dong Y, Zhang Y, Xie L. et al. Risk factors, clinical features, and treatment outcomes of recurrent Mooren Ulcers in China. Cornea 2017; 36: 202-209
- 9 Dua HS, Said DG, Messmer EM. et al. Neurotrophic keratopathy. Prog Ret Eye Res 2018; 66: 107-131
- 10 Durtette C, Hachulla E, Resche-Rigon M. et al. Cogan syndrome: characteristics, outcome and treatment in a French nationwide retrospective study and literature review. Autoimmunity Rev 2017; 16: 1219-1223
- 11 Ebrahimiadib N, Modjitahedi BS, Roohipoor R. et al. Successful treatment strategies in granulomatosis with polyangiitis-associated peripheral ulcerative keratitis. Cornea 2016; 35: 1459-1465
- 12 Hafezi F, Gatzioufas Z, Seiler TG. et al. Corneal Collagen cross-linking for Terrien marginal degeneration. J Refract Surg 2014; 30: 498-500
- 13 Jarade EF, Slim E, Antoune J. et al. Treatment of grade IV diffuse lamellar keratitis with oral doxycycline and topical 10 % sodium citrate. Can J Ophthalmol 2016; 51: 178-184
- 14 Johnson JD, Harissi-Dahger M, Pineda R. et al. Diffuse lamellar keratitis: incidence, associations, outcomes, and a new classification. J Cataract Refract Surg 2001; 27: 1560-1566
- 15 Linebarger EJ, Hardten DR, Lindstrom RL. Diffuse lamellar keratitis: diagnosis and management. J Cataract Refract Surg 2000; 26: 1072-1077
- 16 Lohchab M, Prakash G, Arora T. et al. Surgical management of peripheral corneal thinning disorders. Surv Ophthalmol 2018; 64: 67-78
- 17 Malecha MA, Holland EJ. Peripheral keratitis associated with chronic myelomonocytic leukemia. Cornea 2002; 21: 723-724
- 18 Messmer EM. Therapeutische Optionen bei Keratoconjunctivitis vernalis. Ophthalmologe 2009; 106: 557-562
- 19 Messmer EM. Klinik und Diagnose der neurotrophen Keratopathie. Ophthalmologe 2019; 116: 120-126 doi:10.1007/s00347-018-0822-x
- 20 Messmer EM, Foster CS. Vasculitic peripheral ulcerative keratitis. Surv Ophthalmol 1999; 43: 379-396
- 21 Miyazaki D, Fukushima A, Ohashi Y. et al. Steroid-sparing effect of 0,1 % Tacrolimus eye drop for treatment of shield ulcer and corneal epitheliopathy in refractory allergic ocular disease. Ophthalmology 2017; 124: 287-294
- 22 Özcura F. Successful treatment of staphylococcus-associated marginal keratitis with topical cyclosporine. Graefes Arch Clin Exp Ophthalmol 2010; 248: 1049-1050
- 23 Reddy JC, Basu S, Saboo US. et al. Management, clinical outcomes, and complications of shild ulcers in vernal keratoconjunctivitis. Am J Ophthalmol 2013; 155: 550-559
- 24 Reinstein DZ, Stuart AJ, Vida RS. et al. Incidence and outcomes of sterile multifocal inflammatory keratitis and diffuse lamellar keratitis after SMILE. J Refract Surg 2018; 34: 751-759
- 25 Schwartz GS, Harrison AR, Holland EJ. Etiology of immune stromal (interstitial) keratitis. Cornea 1998; 17: 278-281
- 26 Watanabe R, Ishii T, Yoshida M. et al. Ulcerative keratitis in patients with rheumatoid arthritis in the modern biologic era: a series of eight cases and literature review. Int J Rheum Dis 2017; 20: 225-230
- 27 Yangzes S, Dogra M, Ram J. Interstitial keratitis with corneal perforation as the presenting sign of systemic tuberculosis. Ocul Immunol Inflamm 2019; DOI: 10.1080/09273948.2019.1568504.
- 28 Yazdanyar A, Rizzuti A, Mechel E. et al. Gout Keratitis: a case of peripheral ulcerative keratitis secondary to gout with a review of the literature. Cornea 2018; 37: 379-381
- 29 Zegans ME, Srinivasan M. Moorenʼs ulcer. Int Ophthalmol Clin 1998; 38: 81-88